SeoulTech Develops Artificial Synapses for Next-Gen AI Chips
Seoul National University of Science and Technology (SeoulTech) has developed artificial synapses using organic materials to enhance AI chip efficiency, announced in a press release.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Seoul National University of Science and Technology (SeoulTech) has developed artificial synapses using organic materials to enhance AI chip efficiency, announced in a press release.
Lunit has been selected as the exclusive AI partner for the Valencian Community's breast cancer screening program, marking a significant European deployment.
Medical Horizons and Bowhead Health have announced an exclusive partnership to distribute AI-powered clinical research solutions in Italy, Turkey, and Cyprus, according to a press release.
Nuffield Holdings has announced the addition of Mr Liu Song and Ms Zhang Na as shareholders, aiming to accelerate its growth in Southeast Asia and the Middle East.
Norma has validated its quantum AI algorithms on NVIDIA CUDA-Q, achieving speeds up to 73 times faster for drug development applications.
Astromech, co-founded by Ben Lamm and George Church, has raised $30 million to explore AI applications in biotechnology.
Mount Sinai researchers have developed an AI model that personalizes anticoagulation treatment for atrial fibrillation patients, potentially transforming clinical decision-making.
Researchers at Imperial College London have developed an AI-powered stethoscope capable of diagnosing heart conditions in seconds, according to The Guardian.
Bioneex's AI-powered platform has enabled a Stanford-founded biotech to identify a promising brain-penetrant therapeutic candidate for neurodegenerative diseases.
Binsera Corporation has introduced the world's first offline-capable cloud EHR platform, featuring integrated PACS imaging and AI-driven automation, aimed at enhancing healthcare delivery.
The global Ultrasound AI Market is projected to grow from $2.35 billion in 2025 to $6.88 billion by 2030, driven by advancements in AI and machine learning, according to MarketsandMarkets.
Paubox has launched a generative AI-powered email security solution to enhance protection against sophisticated cyber threats in healthcare, as announced in a press release.
IQSTEL Inc. has announced a partnership with Mobility Tech to integrate AI-powered call center solutions in the U.S. health services sector, as stated in a press release.
OPTEL Group has acquired Vanguard Robotics to enhance its capabilities in pharmaceutical automation, as announced in a press release. This acquisition aims to integrate Vanguard's collaborative robot technology with OPTEL's existing systems.
Fujitsu has announced a new AI agent platform aimed at enhancing operational efficiency in Japan's healthcare sector, developed in collaboration with NVIDIA.
BranchLab has appointed Dan Parkes as Chief Technology Officer to lead its engineering, AI, and data science teams.
MedaSync has secured a strategic investment from Omega Healthcare Investors, Inc., to accelerate the growth of its AI-powered reimbursement software for skilled nursing facilities.
Argent BioPharma Ltd. has signed a binding term sheet to acquire the core assets and intellectual property of AusCann Group Holdings Ltd., enhancing its clinical pipeline and European presence.
Axenya has raised $12 million in a Series A funding round led by Canary and Indicator Capital, aiming to scale its AI-driven corporate health platform.
Veeva Systems has announced a collaboration with Amgen to utilize the Veeva Clinical Platform for advancing clinical trial processes, as stated in a press release.